Todd Foley
InvestorFounderManaging Director at MPM BioImpact · Board director at Moat Biotechnology · Board director at Crossbow Therapeutics · Co-founder and Chairman at Aktis Oncology
Boston, Massachusetts
FoundedAktis Oncology
About
Managing Director who joined the firm in 1999. Serves as Chairman of multiple portfolio company boards and has guided significant M&A outcomes including Semma Therapeutics acquisition by Vertex for $950M and Selexys acquisition by Novartis for $665M.
Contact· self-published, not guessed
Board director at Moat Biotechnology
Intro paths
In turn, Todd can intro founders to Moat Biotechnology's investors below.
Moat Biotechnology's investors · 1
Board director at Crossbow Therapeutics
Intro paths
In turn, Todd can intro founders to Crossbow Therapeutics's investors below.
Crossbow Therapeutics's investors · 7
Co-founder and Chairman at Aktis Oncology
Intro paths
In turn, Todd can intro founders to Aktis Oncology's investors below.
Aktis Oncology's investors · 9
Co-founders at Aktis Oncology
Experience
- MPM BioImpactManaging Directorcurrent1999 — present
- GenentechBusiness Development Intern1998
- Arthur D. LittleAnalyst1994 — 1997
Skills & more
From Todd's professional profile.
Deals · 7
Moat BiotechnologyBoard seat
via MPM BioImpact · filed Oct 2025 · $15.6M raise
Crossbow TherapeuticsBoard seat
via MPM BioImpact · filed Sep 2025 · $80M raise
Firefly Bio, Inc.Board seat
via MPM BioImpact · filed Mar 2024 · $72M raise
Entrada Therapeutics, Inc.Board seat
via MPM BioImpact · filed Apr 2021 · $116.2M raise
HotKnot Therapeutics, Inc.Board seat
via MPM BioImpact · filed Feb 2021 · $72M raise
Tetherex Pharmaceuticals CorpBoard seat
via MPM BioImpact · filed Dec 2020
Clinical inkBoard seat
via MPM BioImpact · filed Dec 2017 · $2.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at MPM BioImpact
Frequently asked questions
- Who is Todd Foley?
- Managing Director who joined the firm in 1999. Serves as Chairman of multiple portfolio company boards and has guided significant M&A outcomes including Semma Therapeutics acquisition by Vertex for $950M and Selexys acquisition by Novartis for $665M.
- Where does Todd Foley work?
- Todd Foley is Co-founder and Chairman of Aktis Oncology and Managing Director at MPM BioImpact and Board director at Moat Biotechnology and Board director at Crossbow Therapeutics.
- What companies did Todd Foley found?
- Todd Foley founded Aktis Oncology.
- What boards does Todd Foley sit on?
- Todd Foley holds tracked board seats at Aktis Oncology, Clinical ink, Crossbow Therapeutics, Entrada Therapeutics, Inc., Firefly Bio, Inc., HotKnot Therapeutics, Inc., Moat Biotechnology, Tetherex Pharmaceuticals Corp.
- Where did Todd Foley go to school?
- Todd Foley studied at Harvard Business School (MBA); Massachusetts Institute of Technology (BS, Chemistry); Guilford High School (high school).
Founder mafias
Massachusetts Institute of Technology mafia546
Also came through, then founded or led a company.
+ 539 more
Harvard Business School mafia323
Also came through, then founded or led a company.
+ 316 more
MPM BioImpact mafia11
Also came through, then founded or led a company.
+ 4 more
Chiasma mafia2
Also came through, then founded or led a company.
Crossbow Therapeutics mafia2
Also came through, then founded or led a company.
Same school
Also attended Harvard Business School2,000
+ 1,994 more
Also attended Massachusetts Institute of Technology1,388
+ 1,382 more
Shared employers
Also worked at Genentech101
+ 95 more
Also worked at Arthur D. Little49
+ 43 more